Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Other Operating Expenses (2020 - 2026)

SkinHealth Systems has reported Other Operating Expenses over the past 6 years, most recently at $23.5 million for Q4 2025.

  • Quarterly Other Operating Expenses fell 11.36% to $23.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.6 million through Dec 2025, down 20.89% year-over-year, with the annual reading at $93.6 million for FY2025, 20.89% down from the prior year.
  • Other Operating Expenses was $23.5 million for Q4 2025 at SkinHealth Systems, up from $20.9 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $44.9 million in Q2 2022 and troughed at $17.1 million in Q1 2021.
  • The 5-year median for Other Operating Expenses is $30.6 million (2023), against an average of $31.4 million.
  • Year-over-year, Other Operating Expenses skyrocketed 448.23% in 2021 and then dropped 29.18% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $37.1 million in 2021, then increased by 5.31% to $39.0 million in 2022, then fell by 17.93% to $32.0 million in 2023, then dropped by 17.17% to $26.5 million in 2024, then dropped by 11.36% to $23.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Other Operating Expenses are $23.5 million (Q4 2025), $20.9 million (Q3 2025), and $23.1 million (Q2 2025).